At a $325M market cap with a Price/Sales of 2.3 and an extreme Price/Book of 21.5, this stock is priced like a growth compounder despite posting a -37.90% operating margin and -5.90% ROIC. The absence of a P/E and Forward P/E, combined with a projected EPS next year of -$0.43, signals earnings instability and zero visibility into near-term profitability. A Piotroski F-Score of 1 is outright distress territory, indicating deteriorating fundamentals across profitability, leverage, and efficiency metrics. With no Altman Z-Score provided and deeply negative operating performance, the burden of proof is on the bulls—this looks far more like a balance-sheet risk than a mispriced growth opportunity.